Arthritis & Rheumatism

Teen vitamin D intake not related to adult RA or SLE risk

(HealthDay)—Dietary vitamin D intake during adolescence does not appear to be associated with the risk of adult-onset rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE), according to research published in the ...

Arthritis & Rheumatism

Predictors of organ damage identified in patients with SLE

(HealthDay)—Patient age, hypertension, and corticosteroid use are the most important predictors of the cumulative organ damage that occurs in patients with systemic lupus erythematosus (SLE), according to research published ...

Diseases, Conditions, Syndromes

Indigenous Australians vulnerable to lupus

(Medical Xpress)—A new study is currently exploring why Indigenous Australians (IA) suffer more frequently and severely from lupus than non-Indigenous Australians (NIA).

Diseases, Conditions, Syndromes

Women with lupus have a higher risk for preeclampsia

New research reports that women with systemic lupus erythematosus (SLE) have a two-fold increase in risk of preeclampsia—a dangerous condition in which pregnant women develop high blood pressure (hypertension) and protein ...

Diseases, Conditions, Syndromes

A surprise mechanism uncovered in the development of lupus

In a study with a surprising outcome, scientists at Yale School of Medicine have discovered that an enzyme complex known for promoting natural resistance to bacteria and fungi unexpectedly inhibits the development of lupus. ...

Arthritis & Rheumatism

Vitamin D supplements may benefit lupus patients

A new clinical study published in BioMedCentral's open access journal Arthritis Research and Therapy provides preliminary evidence that vitamin D supplementation could be considered an immunomodulatory agent for systemic ...

Oncology & Cancer

Belimumab for lupus erythematosus: Added benefit not proven

Belimumab (trade name Benlysta) has been approved since July 2011 as an add-on therapy for adult patients with the autoimmune disease systemic lupus erythematosus (SLE). This monoclonal antibody is only considered as treatment ...

Arthritis & Rheumatism

Belimumab deemed safe for long-term lupus treatment

(HealthDay) -- For patients with systemic lupus erythematosus (SLE), long-term belimumab therapy combined with standard therapy is well tolerated, according to a study published online June 5 in Arthritis & Rheumatism.

page 26 from 28